The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Regulation of MCP-1 chemokine transcription by p53
Open accessAbstract
Background: Our previous studies showed that the expression of the monocyte-chemoattractant protein (MCP)-1, a chemokine, which triggers the infiltration and activation of cells of the monocyte-macrophage lineage, is abrogated in human papillomavirus (HPV)-positive premalignant and malignant cells.In silico analysis of the MCP-1 upstream region proposed a putative p53 binding side about 2.5 kb upstream of the transcriptional start. The aim of this study is to monitor a physiological role of p53 in this process. Results: The proposed p53 binding side could be confirmed in vitro by electrophoretic-mobility-shift assays and in vivo by chromatin immunoprecipitation. Moreover, the availability of p53 is apparently important for chemokine regulation, since TNF-α can induce MCP-1 only in human keratinocytes expressing the viral oncoprotein E7, but not in HPV16 E6 positive cells, where p53 becomes degraded. A general physiological role of p53 in MCP-1 regulation was further substantiated in HPV-negative cells harboring a temperature-sensitive mutant of p53 and in Li-Fraumeni cells, carrying a germ-line mutation of p53. In both cases, non-functional p53 leads to diminished MCP-1 transcription upon TNF-α treatment. In addition, siRNA directed against p53 decreased MCP-1 transcription after TNF-α addition, directly confirming a crosstalk between p53 and MCP-1. Conclusion: These data support the concept that p53 inactivation during carcinogenesis also affects immune surveillance by interfering with chemokine expression and in turn communication with cells of the immunological compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 MCP-1 expression in HPV16 immortalized human keratinocytes and in vitro binding activity of wild-type p53 at the MCP-1 regulatory region. (A) Upper panel: RT-PCR for MCP-1 and GAPDH in HPV16 E6-, E7-, and E6/7 immortalized human foreskin keratinocytes. Cells were treated with TNF-α (250 U/ml) (+) for 6 h. (-) untreated control. The RT-PCR products were separated on 1.5% agarose gel. Lower panel: Western blot analysis of p53. Cytosolic extracts (50 μg per lane) were separated in a 12% SDS-PAGE. Equal loading was confirmed using an actin specific antibody. (B) RT-PCR for MCP-1, p53 and GAPDH in E7-immortalized keratinocytes after lentiviral p53 shRNA delivery. Cells were treated as described in panel A. (C) Schematic overview of the MCP-1 gene. The region -2750 to -2150 bp upstream of the MCP-1 start site harbors two NFκB and one AP-1 binding site. The in silico identified putative p53 binding site (-2422/-2391) relative to NFκB and AP-1 is indicated. Black boxes: exon I-III; white box: polyadenylation site (poly-A), (striped grey box): 3'-regulatory region. (D) Left panel: Electrophoretic mobility shift assay (EMSA): 60 ng of recombinant p53 protein was incubated with [32P]-labeled double-stranded oligonucleotides harboring the wild-type p53-specific RGC-site, the mutated version thereof and the putative MCP-1 p53 binding site, respectively. In addition, binding was also performed in the presence of 200 ng of BSA, anti-GAPDH, DO-1, PAb1801, or PAb421. The positions of free probe, DNA in complex with p53, and DNA in complex with p53 plus supershifting antibodies are indicated by arrows. (D) Right panel: EMSA: comparative binding analysis for wild-type p53 (wtp53) using specific RGC and non-specific RGC mutated versus MCP-1 DNA. DNA binding activities of wild-type p53 (wtp53), p53pro248 and p53pro273 mutants are indicated.](https://figures.cochat.ai/paper-figures/c49108604f9c4076be127aaca54fb9e8/regulation-of-mcp-1-chemokine-transcription-by-p53-figure-1.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Published chromatin immunoprecipitation experiments show a direct association of p53 with the Ccl2 gene regulatory sequences (Hacke et al., 2010; Tang et al., 2012)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Hacke et al., 2010
In the citing paper
“The Ccl2 gene, which may be directly transactivated by p53 (Hacke et al., 2010; Tang et al., 2012)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Hacke et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 1×
“The cDNA for p21 [40] was kindly provided by B.”
MethodDeath Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866 · cited 11×
“Transcription factors such as NFκB or AP-1 can recruit and interact with coactivators such as CBP/ p300, known to possess intrinsic histone acetyltransferase (HAT) activity [57].”
BackgroundInfluentialA System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291 · cited 2×
“A172 cells (1 × 105) were transfected with Effectene Transfection Reagent (Qiagen) according to the manufacturer's instructions using 1 μg pSUPER-p53 for the formation of siRNA targeting p53 transcripts or the respective empty vector [38] as described in the figure legend.”
MethodPapillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024 · cited 2×
“Both oncoproteins exert pleiotropic functions on their host cells, such as inactivation of the major tumour suppressors, p53 and retinoblastoma protein (pRB), respectively [10].”
BackgroundThe TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 1×
“CBP/p300 can also interact and acetylate p53, thereby increasing its DNA binding affinity and biological activity [59].”
BackgroundTumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359 · cited 1×
“Moreover, to rule out that temperature-shifts may affect TNF-α signaling, activation of p38 MAP kinase was examined [50].”
BackgroundThe HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054 · cited 3×
“Since high-risk HPVs are known to degrade p53 via the proteasomal pathway [ 31 ] and p53 is the most frequently mutated tumor suppressor gene in human cancer [32], we anticipated a potential role of p53 in MCP-1 regulation.”
BackgroundInfluentialDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · cited 1×
“This sequence shows high homology (18 out of 20 bp) with the p53 consensus site (5'-(PuPuPuC(A/T)(T/ A)GPyPyPypY)n-3') and comprises two half-sites separated by a spacer of 12 bp, which is within the normal range between 0-13 bp [46].”
BackgroundCancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699 · cited 1×
“Hence, considering cancer as a micro-evolutionary process [12], "high risk" HPVs have developed several evasion or subversion strategies to escape immunological surveillance [13].”
Background
Research works printed but not linked: 1
- Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta. 1993, 1155: 181-205.
Cited by
Unravelling mechanisms of p53-mediated tumour suppression
Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3711 · Cited by 1,387
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
“Published chromatin immunoprecipitation experiments show a direct association of p53 with the Ccl2 gene regula tory sequences (Hacke et al., 2010; Tang et al., 2012), which is consistent with the possibility that p53 directly transacti vates Ccl2.”
InfluentialSasagawa, T., Takagi, H., & Makinoda, S. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0485-5 · Cited by 200
“Normal keratinocytes release MCP-1 in the presence of TNF-a, whereas such secretion is downregulated by the HPV16 E6 protein [22].”
BackgroundCCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
Jin, J., Lin, J., Xu, A., Lou, J., Qian, C., Li, X., Wang, Y., Yu, W., & Tao, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722916 · Cited by 190
“This finding was confirmed in vitro by electrophoretic mobility shift assay and in vivo by ChIP assay (19).”
BackgroundMinocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury
Zhong, Y., & Shultz, R. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206633 · Cited by 160
“…regulate synthesis of leukocyte-recruiting chemo-kines and pro-inflammatory cytokines, including mono-cyte-chemoattractant protein-1 (MCP-1) (Hacke et al., 2010), tumor necrosis factor α (TNFα), interleukin-1β (IL-1β) and interleukin-6 (IL-6) (Olson et al., 2007; Pang et al., 2012; Yu et…”
Metadata
- Authors
- Hacke, K., Rincon-Orozco, B., Buchwalter, G., Siehler, S. Y., Wasylyk, B., Wiesmüller, L., & Rösl, F.
- Affiliations
- German Cancer Research Center (DE)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Universität Ulm (DE)
- Corresponding author
- Rösl, Frank
- Venue
- Molecular Cancer
- Published
- 2010-04-20
- Volume
- 9
- Issue
- 1
- Pages
- 82-82
- ISSN
- 1476-4598 (ISSN-L)
- PMC
- PMC2864217
- OpenAlex
- W2145414107
- Cited by
- 63
- References
- 61
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Wayne State University
- Deutsches Krebsforschungszentrum
- Deutsche Forschungsgemeinschaft
- Institut National de la Santé et de la Recherche Médicale
- Weizmann Institute of Science
- Centre National de la Recherche Scientifique
- Deutsche Krebshilfe
- Institut National Du Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- MCP-1, p53, chemokine transcription, human papillomavirus, E6 oncoprotein, E7 oncoprotein, TNF-α, keratinocytes, p53 binding sites, temperature-sensitive p53 mutant, Li-Fraumeni syndrome, immune surveillance, carcinogenesis, monocyte/macrophage infiltration
- MeSH terms
- Cell Line, Cell Transformation, Neoplastic, Electrophoresis, Polyacrylamide Gel, Enhancer Elements, Genetic, Gene Expression Regulation, Humans, Tumor Necrosis Factor-alpha, Blotting, Northern, Blotting, Western, Keratinocytes, Tumor Suppressor Protein p53, Chemokine CCL2, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Chromatin Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of MCP-1 chemokine transcription by p53. https://app.cochat.ai/papers/10.1186/1476-4598-9-82
- The paper
- Hacke, K., Rincon-Orozco, B., Buchwalter, G., Siehler, S. Y., Wasylyk, B., Wiesmüller, L., & Rösl, F. (2010). Regulation of MCP-1 chemokine transcription by p53. Molecular Cancer. https://doi.org/10.1186/1476-4598-9-82
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.